Oxford Investment Consultants Rebrands as OTIF Ventures
Marking an exciting new chapter, OTIF Ventures builds on a strong EIS track record with one of its most attractive investment pipelines to date.
Marking an exciting new chapter, OTIF Ventures builds on a strong EIS track record with one of its most attractive investment pipelines to date.
A historical cycle of scarcity and survival presents an opportunity for outsized returns in the often misunderstood medical technology investment market.
OTIF Ventures Founding Partner George Robinson joins the Oxford+ Podcast to discuss risk, reward, and the realities of investing in early-stage tech.
“What’s changed in the last 10 years is that we’ve got much better at commercialising science ourselves. We have a culture of entrepreneurship now. It’s now not just acceptable, but encouraged for academics to become entrepreneurs.”
Christopher tells us about how he is applying his experience in law and corporate finance to early-stage tech investment in Oxford.